HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
QSI
Quantum-Si incorporated
There isn't enough reported data to score QSI yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
QSI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Unavailable |
QSI's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
QSI PE Valuation
QSI has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
QSI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect QSI's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
QSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.38 | +$0.29 |
| Q2 2026 | -$0.45 | +$0.23 |
| Q1 2026 | -$0.50 | +$0.18 |
| Q4 2025 | -$0.51 | +$0.20 |
| Q3 2025 | -$0.67 | -$0.03 |
| Q2 2025 | -$0.68 | -$0.05 |
| Q1 2025 | -$0.68 | -$0.03 |
| Q4 2024 | -$0.71 | -$0.03 |
QSI is still losing money, but far less than before: $0.38 per share over the past year, against $0.95 at its worst in late 2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over QSI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over QSI on profitability, with a higher operating margin.
QSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212K | -62% |
| Q2 2026 | $344K | -42% |
| Q1 2026 | $258K | -69% |
| Q4 2025 | $451K | -62% |
| Q3 2025 | $552K | -30% |
| Q2 2025 | $591K | -5% |
| Q1 2025 | $842K | +84% |
| Q4 2024 | $1.2M | +198% |
QSI's revenue has slid since its 2024 peak: $212,000 last quarter, down 62% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -11215% | -4010 points |
| Q2 2026 | -7450% | -2354 points |
| Q1 2026 | -9323% | -6341 points |
| Q4 2025 | -4677% | -2104 points |
| Q3 2025 | -7205% | -3636 points |
| Q2 2025 | -5096% | -844 points |
| Q1 2025 | -2982% | +2129 points |
| Q4 2024 | -2574% | +4397 points |
QSI's operating margin was −11215% last quarter, down 4010 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over QSI on cash generation, producing positive trailing cash flow while its opponent burns cash.
QSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20.6M | +$12.3M |
| Q2 2026 | -$18.5M | +$2M |
| Q1 2026 | -$25.9M | +$1.5M |
| Q4 2025 | -$16.3M | +$8M |
| Q3 2025 | -$32.9M | -$8.8M |
| Q2 2025 | -$20.5M | -$844K |
| Q1 2025 | -$27.5M | -$3.2M |
| Q4 2024 | -$24.3M | -$3.7M |
QSI has burned cash in almost every quarter: −$81M over the past year, against −$105M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over QSI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
QSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +1.2M shares |
| 1 year | +4.8% | +9.9M shares |
| 3 years | +55% | +77.3M shares |
| 5 years | +3972% | +214M shares |
QSI has 219M diluted shares, up 4.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
QSI Net Leverage
QSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
QSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.9 | Neutral |
| Stochastic | 57.2 | Neutral |
QSI's weekly RSI is 54 (neutral) and its Stochastic is 57 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
QSI PE vs Healthcare Sector
QSI has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
QSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.31 | 6.9% below |
| 20 week MA | $1.00 | 22% above |
| 50 week MA | $1.02 | 20% above |
| 100 week MA | $1.36 | 10% below |
| 200 week MA | $1.48 | 18% below |
QSI has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
QSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.88 | $10.2 | +3% |
| 2021 | $10.2 | $8.16 | -20% |
| 2022 | $8.16 | $2.07 | -75% |
| 2023 | $2.07 | $2.01 | -2.9% |
| 2024 | $2.01 | $3.60 | +79% |
| 2025 | $3.60 | $1.23 | -66% |
| 2026 YTD | $1.23 | $1.22 | -0.8% |
QSI has the edge over HIMS on returns for 2026, with the stronger performance.